{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:55:32Z","timestamp":1785552932151,"version":"3.56.0"},"reference-count":6,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8575,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,11]]},"abstract":"<jats:p>11 courses of EACA were given to 9 acutely ill, severely thrombocytopenic patients (platelet count &lt; 20 \u00d7 10<jats:sup>9<\/jats:sup>\/1). 6 patients were being treated for acute leukaemia while 1 each had cyclical amegakaryocytic thrombocytopenia, dysmyelopoietic syndrome and advanced chronic lymphocytic leukaemia. 8 were refractory to HLA\u2010matched platelets and 1 refused blood product transfusion. All had simultaneous major medical complications such as infection and granulocytopenia. The highest dose of EACA used was 24 mg\/d. Improvement in haemostasis was noted in all patients with successful control of epistaxis in 1, control of gastrointestinal bleeding in 3 and lack of significant bleeding for 4\u201329 d in the remaining 5 patients. The only toxicity was dose\u2010related nausea. Since this patient group was at extremely high risk for haemorrhage, we conclude that EACA is safe and useful in the management of thrombocytopenia including that occurring during leukaemic induction.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb02818.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T19:00:30Z","timestamp":1280948430000},"page":"497-500","source":"Crossref","is-referenced-by-count":45,"title":["Anti\u2010fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients"],"prefix":"10.1111","volume":"35","author":[{"given":"Harinder S.","family":"Garewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G. M.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1966.tb04691.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V51.5.781.781","article-title":"Platelet transfusion therapy: Optimal dose selection with a combination of lymphocytotoxicity and platelet fluorescence tests","volume":"51","author":"Brand A.","year":"1978","journal-title":"Blood"},{"key":"e_1_2_1_4_2","first-page":"1","article-title":"Epsilon aminocaproic acid (EACA)","volume":"5","author":"Griffin JD","year":"1978","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1980.03300270023023","article-title":"Aminocaproic acid use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia","volume":"243","author":"Gardner FH","year":"1980","journal-title":"JAMA"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V60.2.309.bloodjournal602309"},{"issue":"1","key":"e_1_2_1_7_2","first-page":"202a","article-title":"Antifibrinolytic therapy for bleeding control during remission induction for acute leukemia","volume":"62","author":"Gallardo RL","year":"1983","journal-title":"Blood"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb02818.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb02818.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T19:16:30Z","timestamp":1697829390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb02818.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb02818.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb02818.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}